StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Reaktion

Potassium Phosphate, Tribasic → 5-(2-chloro-4-(trifluoromethyl)phenyl)-N-(pyrimidin-4-yl)naphthalene-2-sulfonamide

HRID 1473311
Drucken

Reaktionsgleichung

Reaktionsgleichung von HRID 1473311
Br[C:2]1[CH:11]=[CH:10][CH:9]=[C:8]2[C:3]=1[CH:4]=[CH:5][C:6]([S:12]([NH:15][C:16]1[CH:21]=[CH:20][N:19]=[CH:18][N:17]=1)(=[O:14])=[O:13])=[CH:7]2.[Cl:22][C:23]1[CH:28]=[C:27]([C:29]([F:32])([F:31])[F:30])[CH:26]=[CH:25][C:24]=1B(O)O.P([O-])([O-])([O-])=O.[K+].[K+].[K+]>C(C1C(C(C)(C)C)=C([Pd]Cl)C=CC=1NC)(C)(C)C.CCOC(C)=O>[Cl:22][C:23]1[CH:28]=[C:27]([C:29]([F:30])([F:31])[F:32])[CH:26]=[CH:25][C:24]=1[C:2]1[CH:11]=[CH:10][CH:9]=[C:8]2[C:3]=1[CH:4]=[CH:5][C:6]([S:12]([NH:15][C:16]1[CH:21]=[CH:20][N:19]=[CH:18][N:17]=1)(=[O:14])=[O:13])=[CH:7]2
KomponentenReaktionsbedingungenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

6

Edukt 3

HCID 62657Potassium Phosphate, TribasicHCID 2783251[2-Chloro-4-(trifluoromethyl)phenyl]boronic acidHCID 866873675-bromo-N-(pyrimidin-4-yl)naphthalene-2-sulfonamide2×

Produkt 1

HCID 866873685-(2-chloro-4-(trifluoromethyl)phenyl)-N-(pyrimidin-4-yl)naphthalene-2-sulfonamideAusbeute 75 %

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 178482226
HCID 178482226, Verbindung
Katalysator
HCID 8857Ethyl AcetateLösungsmittel2×

Reaktionsbedingungen

Temperatur
90 °C

Versuchsvorschrift

A microwave vial was charged with 5-bromo-N-(pyrimidin-4-yl)naphthalene-2-sulfonamide (Intermediate W) (0.508 g, 1.395 mmol), (2-chloro-4-(trifluoromethyl)phenyl)boronic acid (0.469 g, 2.092 mmol), potassium phosphate (0.888 g, 4.18 mmol), and 1,1-bis[(di-t-butyl-p-methylaminophenyl]palladium(ii) chloride (0.099 g, 0.139 mmol). The vial was sealed with a septum cap and flushed with N2. Dioxane (3.49 mL) and water (1.162 mL) were added and the mixture was sparged for 5 min with N2. The mixture was heated in a microwave at 90° C. for 30 min. The resulting mixture was diluted with EtOAc (5 mL) and decanted from insoluble solids. The resulting solution was concentrated for purification by MPLC. The residue was taken up in minimal CH2Cl2 and absorbed onto a 5 g loading cartridge and passed through a silica gel column (12 g) using a 98:2 Heptane:EtOAc (with 5% EtOH additive) to 100% EtOAc (5% EtOH additive) gradient to afford 5-(2-chloro-4-(trifluoromethyl)phenyl)-N-(pyrimidin-4-yl)naphthalene-2-sulfonamide (0.485 g, 1.046 mmol) as a orange amorphous solid.

Aufarbeitung

  1. customThe vial was sealed with a septum
  2. customcap
  3. customflushed with N2
  4. additionDioxane (3.49 mL) and water (1.162 mL) were added
  5. customthe mixture was sparged for 5 min with N2
  6. additionThe resulting mixture was diluted with EtOAc (5 mL)
  7. customdecanted from insoluble solids
  8. concentrationThe resulting solution was concentrated for purification by MPLC
  9. customabsorbed onto a 5 g loading cartridge

Quellen und Nachweise

ORD-Eintrag
ord-da7aad69807f466191e92d93a9268dd8
Quelldatensatz
uspto-grants-2015_04
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US09012443B2

Notizen zur Reaktion

Auf dieser SeiteKomponentenReaktionsbedingungenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion